253 related articles for article (PubMed ID: 29720384)
1. Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
Girard R; Zeineddine HA; Koskimäki J; Fam MD; Cao Y; Shi C; Moore T; Lightle R; Stadnik A; Chaudagar K; Polster S; Shenkar R; Duggan R; Leclerc D; Whitehead KJ; Li DY; Awad IA
Circ Res; 2018 Jun; 122(12):1716-1721. PubMed ID: 29720384
[TBL] [Abstract][Full Text] [Related]
2. Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
Girard R; Zeineddine HA; Fam MD; Mayampurath A; Cao Y; Shi C; Shenkar R; Polster SP; Jesselson M; Duggan R; Mikati AG; Christoforidis G; Andrade J; Whitehead KJ; Li DY; Awad IA
Transl Stroke Res; 2018 Feb; 9(1):34-43. PubMed ID: 28819935
[TBL] [Abstract][Full Text] [Related]
3. Perfusion and Permeability MRI Predicts Future Cavernous Angioma Hemorrhage and Growth.
Sone JY; Hobson N; Srinath A; Romanos SG; Li Y; Carrión-Penagos J; Shkoukani A; Stadnik A; Piedad K; Lightle R; Moore T; DeBiasse D; Bi D; Shenkar R; Carroll T; Ji Y; Girard R; Awad IA
J Magn Reson Imaging; 2022 May; 55(5):1440-1449. PubMed ID: 34558140
[TBL] [Abstract][Full Text] [Related]
4. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
Girard R; Fam MD; Zeineddine HA; Tan H; Mikati AG; Shi C; Jesselson M; Shenkar R; Wu M; Cao Y; Hobson N; Larsson HBW; Christoforidis GA; Awad IA
J Neurosurg; 2017 Jul; 127(1):102-110. PubMed ID: 27494817
[TBL] [Abstract][Full Text] [Related]
5. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
Girard R; Li Y; Stadnik A; Shenkar R; Hobson N; Romanos S; Srinath A; Moore T; Lightle R; Shkoukani A; Akers A; Carroll T; Christoforidis GA; Koenig JI; Lee C; Piedad K; Greenberg SM; Kim H; Flemming KD; Ji Y; Awad IA
Neurosurgery; 2021 Feb; 88(3):686-697. PubMed ID: 33469662
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of cavernous angioma with symptomatic hemorrhage.
Lyne SB; Girard R; Koskimäki J; Zeineddine HA; Zhang D; Cao Y; Li Y; Stadnik A; Moore T; Lightle R; Shi C; Shenkar R; Carrión-Penagos J; Polster SP; Romanos S; Akers A; Lopez-Ramirez M; Whitehead KJ; Kahn ML; Ginsberg MH; Marchuk DA; Awad IA
JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31217347
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
[TBL] [Abstract][Full Text] [Related]
8. The association between high VEGF levels and multiple probable punctuate cavernous malformations.
Abe T; Morishige M; Ooba H; Kamida T; Fujiki M; Kobayashi H; Sakoda T; Kimba Y
Acta Neurochir (Wien); 2009 Jul; 151(7):855-9. PubMed ID: 19479188
[TBL] [Abstract][Full Text] [Related]
9. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
Zeineddine HA; Girard R; Cao Y; Hobson N; Fam MD; Stadnik A; Tan H; Shen J; Chaudagar K; Shenkar R; Thompson RE; McBee N; Hanley D; Carroll T; Christoforidis GA; Awad IA
J Magn Reson Imaging; 2018 Apr; 47(4):1133-1138. PubMed ID: 28791783
[TBL] [Abstract][Full Text] [Related]
10. Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
Carrión-Penagos J; Zeineddine HA; Polster SP; Girard R; Lyne SB; Koskimäki J; Romanos S; Srinath A; Zhang D; Cao Y; Stadnik A; Piedad K; Shenkar R; Awad IA
J Neurosurg; 2020 Apr; 134(3):1147-1154. PubMed ID: 32244216
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations.
Tan H; Zhang L; Mikati AG; Girard R; Khanna O; Fam MD; Liu T; Wang Y; Edelman RR; Christoforidis G; Awad IA
AJNR Am J Neuroradiol; 2016 Jul; 37(7):1209-15. PubMed ID: 26965464
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Physical Activity on Cavernous Malformation Hemorrhage.
Joseph NK; Kumar S; Lanzino G; Flemming KD
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104629. PubMed ID: 32147026
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.
Choquet H; Pawlikowska L; Nelson J; McCulloch CE; Akers A; Baca B; Khan Y; Hart B; Morrison L; Kim H;
Cerebrovasc Dis; 2014; 38(6):433-40. PubMed ID: 25472749
[TBL] [Abstract][Full Text] [Related]
14. Circulating Blood Prognostic Biomarker Signatures for Hemorrhagic Cerebral Cavernous Malformations (CCMs).
Croft J; Grajeda B; Aguirre LA; Abou-Fadel JS; Ellis CC; Estevao I; Almeida IC; Zhang J
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731959
[TBL] [Abstract][Full Text] [Related]
15. Cavernous angiomas: deconstructing a neurosurgical disease.
Awad IA; Polster SP
J Neurosurg; 2019 Jul; 131(1):1-13. PubMed ID: 31261134
[TBL] [Abstract][Full Text] [Related]
16. Association of Variants in FCGR2A, PTPN2, and GM-CSF with Cerebral Cavernous Malformation: Potential Biomarkers for a Symptomatic Disease.
da Fontoura Galváo G; Fontes-Dantas FL; da Silva EV; Alves-Leon SV; de Souza JM
Curr Neurovasc Res; 2021; 18(2):172-180. PubMed ID: 34082682
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic cerebral cavernous angiomas associated with plasma marker signature.
Chehuen Bicalho V; da Fontoura Galvão G; Lima Fontes-Dantas F; Paulo da Costa Gonçalves J; Dutra de Araujo A; Carolina França L; Emílio Corrêa Leite P; Campolina Vidal D; Castro Filho R; Vieira Alves-Leon S; Marcondes de Souza J
J Clin Neurosci; 2021 Jul; 89():258-263. PubMed ID: 34119277
[No Abstract] [Full Text] [Related]
18. Perfusion and permeability as diagnostic biomarkers of cavernous angioma with symptomatic hemorrhage.
Sone JY; Li Y; Hobson N; Romanos SG; Srinath A; Lyne SB; Shkoukani A; Carrión-Penagos J; Stadnik A; Piedad K; Lightle R; Moore T; Li Y; Bi D; Shenkar R; Carroll T; Ji Y; Girard R; Awad IA
J Cereb Blood Flow Metab; 2021 Nov; 41(11):2944-2956. PubMed ID: 34039038
[TBL] [Abstract][Full Text] [Related]
19. Natural history of familial cerebral cavernous malformation syndrome in children: a multicenter cohort study.
Geraldo AF; Alves CAPF; Luis A; Tortora D; Guimarães J; Abreu D; Reimão S; Pavanello M; de Marco P; Scala M; Capra V; Vaz R; Rossi A; Schwartz ES; Mankad K; Severino M
Neuroradiology; 2023 Feb; 65(2):401-414. PubMed ID: 36198887
[TBL] [Abstract][Full Text] [Related]
20. Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level.
Flemming KD; Kumar S; Brown RD; Singh RJ; Whitehead K; McCreath L; Lanzino G
Cerebrovasc Dis; 2020; 49(2):216-222. PubMed ID: 32348981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
